Biophan Technologies, Inc., a developer of next-generation medical technology, has announced that representatives of the Company will present the Company's breakthrough nanotechnology-based healthcare applications and its business strategies to monetize its innovations at the 13th Foresight Conference on Advanced Nanotechnology, scheduled to take place October 22 - 27, in San Francisco, CA.
An update on the Company's breakthrough nanotechnology innovations will be presented, including solutions to improve safety and effectiveness of Magnetic Resonance Imaging (MRI) in healthcare, unique thermoelectric battery technology designed to power implantable medical devices, advanced contrast agents for medical imaging, and next-generation applications for the drug delivery and drug-elution marketplace. This presentation is scheduled for October 25, at 12:30 p.m. Pacific.
In addition, the Company's business strategy will be presented in the conference's "Public Equity Roundtable" presentation, scheduled for 5:45 p.m. on October 25.
"The Foresight conference will provide valuable investor and industry exposure for our array of innovative nanotechnology applications," said Mr. Weiner. "Our business plan is designed to leverage these next-generation solutions to enable a range of products for various healthcare market segments, such as advanced drug-delivery systems, an implantable biothermal power supply, enhanced MRI imaging, and others."
The Company recently launched an initiative to expand its presence in cardiovascular diagnostic and therapeutic devices, one of the fastest-growing segments of the biomedical industry, with the potential to reach nearly $28 billion before the end of this decade.
